However, some researchers found that TGFβR2 as a proto-oncogene, the expression was significantly higher in NSCLC tissues than in non-neoplastic tissues, and high expression of TGFβR2 was a critical risk factor for reduced survival in NSCLC patients [7]. The gene discussed is TGFBR2; the disease is non-small cell lung carcinoma.